Berkshire Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $267K | Buy |
911
+1
| +0.1% | +$329 | 0.01% | 229 |
|
|
2025
Q4 | $319K | Sell |
910
-126
| -12% | -$42.6K | 0.01% | 213 |
|
|
2025
Q3 | $335K | Sell |
1,036
-398
| -28% | -$124K | 0.01% | 231 |
|
|
2025
Q2 | $558K | Sell |
1,434
-765
| -35% | -$308K | 0.03% | 179 |
|
|
2025
Q1 | $907K | Buy |
2,199
+785
| +56% | +$315K | 0.04% | 144 |
|
|
2024
Q4 | $567K | Sell |
1,414
-12
| -0.8% | -$5.02K | 0.03% | 178 |
|
|
2024
Q3 | $773K | Hold |
1,426
| – | – | 0.04% | 152 |
|
|
2024
Q2 | $773K | Buy |
1,426
+856
| +150% | +$452K | 0.04% | 153 |
|
|
2024
Q1 | $296K | Sell |
570
-10
| -2% | -$4.97K | 0.02% | 203 |
|
|
2023
Q4 | $274K | Buy |
580
+7
| +1% | +$3.24K | 0.02% | 206 |
|
|
2023
Q3 | $249K | Hold |
573
| – | – | 0.02% | 210 |
|
|
2023
Q2 | $255K | Sell |
573
-29
| -5% | -$13.4K | 0.02% | 209 |
|
|
2023
Q1 | $277K | Buy |
+602
| New | +$286K | 0.02% | 196 |
|
|
2022
Q4 | – | Sell |
-576
| Closed | -$262K | – | 163 |
|
|
2022
Q3 | $262K | Sell |
576
-78
| -12% | -$37.3K | 0.02% | 183 |
|
|
2022
Q2 | $316K | Hold |
654
| – | – | 0.02% | 178 |
|
|
2022
Q1 | $321K | Sell |
654
-335
| -34% | -$153K | 0.02% | 171 |
|
|
2021
Q4 | $458K | Sell |
989
-129
| -12% | -$54.3K | 0.03% | 172 |
|
|
2021
Q3 | $417K | Buy |
1,118
+140
| +14% | +$53.2K | 0.03% | 177 |
|
|
2021
Q2 | $373K | Buy |
978
+18
| +2% | +$6.88K | 0.03% | 182 |
|
|
2021
Q1 | $345K | Sell |
960
-482
| -33% | -$155K | 0.03% | 176 |
|
|
2020
Q4 | $463K | Buy |
1,442
+602
| +72% | +$185K | 0.04% | 152 |
|
|
2020
Q3 | $226K | Hold |
840
| – | – | 0.02% | 154 |
|
|
2020
Q2 | $221K | Sell |
840
-652
| -44% | -$174K | 0.02% | 155 |
|
|
2020
Q1 | $339K | Buy |
1,492
+573
| +62% | +$156K | 0.04% | 152 |
|
|
2019
Q4 | $278K | Buy |
919
+11
| +1% | +$3.03K | 0.02% | 162 |
|
|
2019
Q3 | $218K | Sell |
908
-270
| -23% | -$74K | 0.02% | 196 |
|
|
2019
Q2 | $332K | Hold |
1,178
| – | – | 0.03% | 170 |
|
|
2019
Q1 | $338K | Sell |
1,178
-555
| -32% | -$161K | 0.03% | 176 |
|
|
2018
Q4 | $455K | Hold |
1,733
| – | – | 0.04% | 146 |
|
|
2018
Q3 | $475K | Hold |
1,733
| – | – | 0.04% | 147 |
|
|
2018
Q2 | $413K | Hold |
1,733
| – | – | 0.04% | 148 |
|
|
2018
Q1 | $381K | Hold |
1,733
| – | – | 0.04% | 150 |
|
|
2017
Q4 | $390K | Sell |
1,733
-100
| -5% | -$21.3K | 0.04% | 157 |
|
|
2017
Q3 | $348K | Hold |
1,833
| – | – | 0.04% | 152 |
|
|
2017
Q2 | $345K | Sell |
1,833
-46
| -2% | -$8.27K | 0.04% | 149 |
|
|
2017
Q1 | $311K | Sell |
1,879
-150
| -7% | -$23.9K | 0.04% | 155 |
|
|
2016
Q4 | $292K | Sell |
2,029
-90
| -4% | -$12.1K | 0.04% | 152 |
|
|
2016
Q3 | $266K | Buy |
+2,119
| New | +$274K | 0.04% | 153 |
|
Other funds holding ELV
VCM
VPM
Berkshire Asset Management's ELV Position: Q1 2026 in Review
Berkshire Asset Management increased its Elevance Health (ELV) stake by 0.11% in Q1 2026, buying an estimated $329 and bringing the position to 911 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #229.
Berkshire Asset Management first reported a position in ELV in Q3 2016 and has held it in 38 quarters since. The position peaked at $907K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Berkshire Asset Management held 911 shares of Elevance Health worth $267K as of Q1 2026.
- Berkshire Asset Management bought 1 Elevance Health share in Q1 2026, an estimated $329.
- Elevance Health made up 0.01% of Berkshire Asset Management's portfolio in Q1 2026, its #229 holding.
- Berkshire Asset Management first reported a position in Elevance Health in Q3 2016 and has held it in 38 quarters since.
- Berkshire Asset Management's Elevance Health position peaked at $907K in Q1 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Berkshire Asset Management's 13F filing for Q1 2026, filed 11 May 2026.